These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30556952)

  • 1. Use of proton pump inhibitors among Danish children: A 16-year register-based nationwide study.
    Aznar-Lou I; Reilev M; Lødrup AB; Rubio-Valera M; Haastrup PF; Pottegård A
    Basic Clin Pharmacol Toxicol; 2019 Jun; 124(6):704-710. PubMed ID: 30556952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
    Luo H; Fan Q; Xiao S; Chen K
    BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of proton pump inhibitors anti-ulcer drugs use in the Araba district primary care area].
    Martínez Gorostiaga J; Echevarría Orella E; Calvo Hernáez B
    Rev Esp Salud Publica; 2018 Aug; 92():. PubMed ID: 30100604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in prescribing proton pump inhibitors in Taiwan: 1997 - 2000.
    Chen TJ; Chou LF; Hwang SJ
    Int J Clin Pharmacol Ther; 2003 May; 41(5):207-12. PubMed ID: 12776811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General practice variation when initiating long-term prescribing of proton pump inhibitors: a nationwide cohort study.
    Haastrup PF; Rasmussen S; Hansen JM; Christensen RD; Søndergaard J; Jarbøl DE
    BMC Fam Pract; 2016 May; 17():57. PubMed ID: 27233634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors: a study of GPs' prescribing.
    Jones MI; Greenfield SM; Jowett S; Bradley CP; Seal R
    Fam Pract; 2001 Jun; 18(3):333-8. PubMed ID: 11356744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010-2018.
    Rückert-Eheberg IM; Nolde M; Ahn N; Tauscher M; Gerlach R; Güntner F; Günter A; Meisinger C; Linseisen J; Amann U; Baumeister SE
    Eur J Clin Pharmacol; 2022 Apr; 78(4):657-667. PubMed ID: 34877614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study.
    Liu Y; Zhu X; Li R; Zhang J; Zhang F
    BMJ Open; 2020 Nov; 10(11):e040473. PubMed ID: 33243802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-pump inhibitor utilization associated with the change to nonpreferred formulary status for esomeprazole in the TRICARE formulary.
    Linton A; Bacon T; Peterson M
    J Manag Care Pharm; 2009; 15(1):42-54. PubMed ID: 19125549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: A total population register-linkage study.
    Sidorchuk A; Isomura K; Molero Y; Hellner C; Lichtenstein P; Chang Z; Franck J; Fernández de la Cruz L; Mataix-Cols D
    PLoS Med; 2018 Aug; 15(8):e1002635. PubMed ID: 30086134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Prescriptions of Proton Pump Inhibitors in France (2009-2019): A Time-Series Analysis of Trends and Practice Guidelines Impact.
    Yang S; Trinh NTH; Chalumeau M; Kaguelidou F; Ruemmele FM; Milic D; Lemaitre M; Cohen JF; Taine M
    J Pediatr; 2022 Jun; 245():158-164.e4. PubMed ID: 35120983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing efficiency of proton pump inhibitors in China: influence and future directions.
    Zeng W; Finlayson AE; Shankar S; de Bruyn W; Godman B
    BMC Health Serv Res; 2015 Jan; 15():11. PubMed ID: 25609265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
    Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK
    J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical and non-medical predictors of initiating long-term use of proton pump inhibitors: a nationwide cohort study of first-time users during a 10-year period.
    Haastrup PF; Paulsen MS; Christensen RD; Søndergaard J; Hansen JM; Jarbøl DE
    Aliment Pharmacol Ther; 2016 Jul; 44(1):78-87. PubMed ID: 27137875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Study of Off-label Proton Pump Inhibitor Use Among New Zealand Infants in the First Year of Life (2005-2012).
    Blank ML; Parkin L
    J Pediatr Gastroenterol Nutr; 2017 Aug; 65(2):179-184. PubMed ID: 28403034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.
    Lassalle M; Le Tri T; Bardou M; Biour M; Kirchgesner J; Rouby F; Dumarcet N; Zureik M; Dray-Spira R
    Eur J Clin Pharmacol; 2020 Mar; 76(3):449-457. PubMed ID: 31838548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validity of proton pump inhibitors' prescriptions in a department of internal medicine].
    Marie I; Moutot A; Tharrasse A; Hellot MF; Robaday S; Hervé F; Lévesque H
    Rev Med Interne; 2007 Feb; 28(2):86-93. PubMed ID: 17092611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of hospital drug formulary policies on the prescribing patterns of proton pump inhibitors in primary care.
    Larsen MD; Schou M; Kristiansen AS; Hallas J
    Eur J Clin Pharmacol; 2014 Jul; 70(7):859-65. PubMed ID: 24770928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study.
    Pottegård A; Broe A; Hallas J; de Muckadell OB; Lassen AT; Lødrup AB
    Therap Adv Gastroenterol; 2016 Sep; 9(5):671-8. PubMed ID: 27582879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia.
    Wu J; Dickinson S; Elgebaly Z; Blogg S; Heaney A; Soo Y; Daniels B; Weekes L
    BMC Fam Pract; 2020 May; 21(1):85. PubMed ID: 32386520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.